Provident Healthcare Partners Advises Verdi Oncology on a Transaction with The US Oncology Network
BOSTON and NEW YORK , Dec. 15, 2023 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Verdi Oncology, Inc. ("Verdi"), a portfolio company of Pharos Capital Group ("Pharos"), on a transaction with The US Oncology Network ("The Network"), pursuant to which Nashville Oncology Associates ("NOA"), based in Tennessee, and Horizon Oncology ("Horizon"), based in Indiana, have joined The Network.
- BOSTON and NEW YORK , Dec. 15, 2023 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Verdi Oncology, Inc. ("Verdi"), a portfolio company of Pharos Capital Group ("Pharos"), on a transaction with The US Oncology Network ("The Network"), pursuant to which Nashville Oncology Associates ("NOA"), based in Tennessee, and Horizon Oncology ("Horizon"), based in Indiana, have joined The Network.
- NOA and Horizon offer comprehensive oncology services using advanced diagnostic methods, therapeutic options, and access to innovative clinical trials.
- We were very pleased with the guidance and insight the Provident team provided throughout this process.
- "We were very pleased with the guidance and insight the Provident team provided throughout this process," commented Bill Herman, CEO of Verdi.